Menu
Prof. Kushner is a pediatric ophthalmologist specializing in the treatment of strabismus. He pioneered research and surgery for strabismus and demonstrated marked improvement in the visual fields of those recovering from strabismus surgery. Professor Kushner was the Director of the Pediatric Eye and Adult Strabismus Clinic at the University of Wisconsin, Madison and is currently a Professor Emeritus in the Department of Ophthalmology and Visual Science. He served as Secretary for the Program of the AAPOS, Editor-in-Chief of the Journal of Pediatric Ophthalmology, Founding Editor of the Journal of AAPOS, and Editor-in-Chief of the Journal of Binocular Vision and Ocular Motility. He has published over 200 peer reviewed manuscripts, authored 41 textbook chapters, edited three textbooks, and was sole author of another two textbooks. He was listed as one of the “20 Most Innovative Pediatric Surgeons Alive Today” by Top Master’s in Health Care Administration.
Prof. Levi is Professor of Optometry and Vision Science at the University of California, Berkeley, where he also served as Dean of the School of Optometry. Prof. Levi was elected Fellow of the Optical Society of America for his research contributions in the areas of amblyopia and 3D vision. His research has been published in approximately 300 scientific papers and two books. He has received numerous awards including the Glenn Fry Award, the Garland Clay Award and the Prentice Medal from the American Academy of Optometry, and most recently the 2016 Edgar D. Tillyer Award from the Optical Society of America for his groundbreaking work on treating amblyopia. Prof. Levi is also the Editor-in-Chief of the Journal of Vision.
Anne F. Ratner Professor of Ophthalmology & Pediatrics at the University of California, San Diego where he is the Director of the Ratner Children’s Eye Center at the Shiley Eye Institute. The author of over 130 articles and book chapters, he is the founder of the International Pediatric-Ophthalmology Internet discussion group, a past Chair of the Section on Ophthalmology for the American Academy of Pediatrics and co-editor of their book on Ophthalmology for the Pediatrician. He received the Innovation Prize from the Swiss Academy of Ophthalmology for the work he did with Ken Nischal in founding the World Society of Pediatric Ophthalmology & Strabismus which they co-direct. Dr. Granet has received the Lifetime Achievement Award from the American Association of Pediatric Ophthalmology and Strabismus and has been voted perennially by his peers into US News Best Doctors of America. This year he was named on the Ophthalmologists “Top 50 Power List” as a Champion of Change. In addition, Dr. Granet serves as the host for the award-winning medical television show “Health Matters”.
Prof. Belkin, one of NovaSight's founders, is Professor Emeritus in the Department of Ophthalmology at Tel Aviv University, and a senior advisor to the Singapore Eye Research Institute. He is also the Co-founder and former president of the Israel Society of Eye and Vision Research. He was also Head of Pediatric Ophthalmology Services at the Hadassah University Hospital and Sheba Medical Center. Prof. Belkin holds over 25 patents, has published more than 250 scientific publications, innovated the technology behind Optonol, and served as the company’s CMO prior to its acquisition by Alcon for over US$200 million. Prof. Belkin was also Head of Research and Development for the Medical Department of the Israeli Military, and Chairman of the Tel Aviv University Department of Ophthalmology.
Tamara Wygnanski-Jaffe, M.D., is a pediatric ophthalmologist, and head of the pediatric ophthalmology and strabismus service at the Sheba Medical Center. She was director of the pediatric ophthalmology and strabismus society in Israel and chair of the research committee of the International Pediatric Ophthalmology and Strabismus Council for 6 years, where she is presently the Secretary Treasurer. She is currently associate professor at the Sacker Faculty of Medicine, Tel Aviv University. Her research has been published in over 50 scientific peer reviewed papers.
© 2022 NovaSight | All Rights Reserved | NS-00779-R06
CureSight™ and EyeSwift®PRO devices are CE marked in accordance with EU Medical Device Regulation 2017/745.
CureSight™ is an FDA 510(K) cleared device.
Caution: The EyeSwift®PRO system is an Investigational Device, Limited By Federal (Or United States) Law To Investigational Use.
Currently, TrackSightTM is not approved for sales in any country.
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
Your data will be handled in accordance with our Privacy
Policy. In the event that a child’s or minor’s information is
being submitted as part of this form, we hereby request
that such information be submitted solely by the legal
guardian of such child or minor.
This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information
